FLASHDOSE - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 78543928
Serial Number
78543928
Word Mark
FLASHDOSE
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2009-08-24
Filing Date
2005-01-07
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2006-05-02
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
REIHNER, DAVID C
Statements
Goods and Services
Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
Pseudo Mark
FLASH DOSE
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2005-01-19
Primary Code
005
Correspondences
Name
James R. Menker
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration2048066
Trademark Events
Event DateEvent Description
2005-01-19NEW APPLICATION ENTERED IN TRAM
2005-04-13TEAS CHANGE OF CORRESPONDENCE RECEIVED
2005-08-09ASSIGNED TO EXAMINER
2005-08-09NON-FINAL ACTION WRITTEN
2005-08-09NON-FINAL ACTION E-MAILED
2006-02-09TEAS RESPONSE TO OFFICE ACTION RECEIVED
2006-02-09CORRESPONDENCE RECEIVED IN LAW OFFICE
2006-03-03TEAS/EMAIL CORRESPONDENCE ENTERED
2006-03-08APPROVED FOR PUB - PRINCIPAL REGISTER
2006-03-10ASSIGNED TO LIE
2006-03-14LAW OFFICE PUBLICATION REVIEW COMPLETED
2006-04-12NOTICE OF PUBLICATION
2006-05-02PUBLISHED FOR OPPOSITION
2006-07-25NOA MAILED - SOU REQUIRED FROM APPLICANT
2006-11-09TEAS EXTENSION RECEIVED
2006-11-09EXTENSION 1 FILED
2006-12-27EXTENSION 1 GRANTED
2007-07-12TEAS EXTENSION RECEIVED
2007-07-12EXTENSION 2 FILED
2007-09-14EXTENSION 2 GRANTED
2007-09-29TEAS CHANGE OF CORRESPONDENCE RECEIVED
2008-01-18TEAS EXTENSION RECEIVED
2008-01-18EXTENSION 3 FILED
2008-02-07EXTENSION 3 GRANTED
2008-07-17TEAS EXTENSION RECEIVED
2008-07-17EXTENSION 4 FILED
2008-07-17EXTENSION 4 GRANTED
2009-01-22TEAS CHANGE OF OWNER ADDRESS RECEIVED
2009-01-22APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2009-01-22TEAS EXTENSION RECEIVED
2009-02-05CASE ASSIGNED TO INTENT TO USE PARALEGAL
2009-01-22EXTENSION 5 FILED
2009-02-05EXTENSION 5 GRANTED
2009-06-17ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2009-08-24ABANDONMENT - NO USE STATEMENT FILED
2009-08-24ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
2010-10-13ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY